ADM and Sepsis: Adrenomedullin is markedly elevated in patients with sepsis and in patients with acute HF, probably as a compensatory mechanism against fluid overload and tissue congestion.213 Adrecizumab is a monoclonal, non-neutralizing antibody that stabilizes adrenomedullin, ‘trapping’ it in the circulation without blocking adrenomedullin receptor signalling.